Search Results - Yaxiong Zhang

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Phase I Clinical Trial of CVL218, a Novel PARP1/2 Inhibitor, in Patients with Advanced Solid Tumors

    Phase I Clinical Trial of CVL218, a Novel PARP1/2 Inhibitor, in Patients with Advanced Solid Tumors by Zihong Chen, Gang Chen, Yuxiang Ma, Hongyun Zhao, Jianhua Zhan, Yan Huang, Yunpeng Yang, Yuanyuan Zhao, Shaodong Hong, Ting Zhou, Wenfeng Fang, Li Zhang, Yaxiong Zhang

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: